BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36482232)

  • 21. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
    Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
    Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer.
    Nichols HB; Trentham-Dietz A; Newcomb PA; Egan KM; Titus LJ; Hampton JM; Visvanathan K
    Breast Cancer Res; 2013; 15(5):R99. PubMed ID: 24152546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial.
    Manson JE; Aragaki AK; Bassuk SS; Chlebowski RT; Anderson GL; Rossouw JE; Howard BV; Thomson CA; Stefanick ML; Kaunitz AM; Crandall CJ; Eaton CB; Henderson VW; Liu S; Luo J; Rohan T; Shadyab AH; Wells G; Wactawski-Wende J; Prentice RL;
    Ann Intern Med; 2019 Sep; 171(6):406-414. PubMed ID: 31499528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
    Wang SM; Pfeiffer RM; Gierach GL; Falk RT
    Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Revised Markov Model Evaluating Oophorectomy at the Time of Hysterectomy for Benign Indication: Age 65 Years Revisited.
    Rush SK; Ma X; Newton MA; Rose SL
    Obstet Gynecol; 2022 May; 139(5):735-744. PubMed ID: 35576331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid cancer after hysterectomy and oophorectomy: a nationwide cohort study.
    Kim M; Kim BH; Lee H; Nam H; Park S; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Kim IJ
    Eur J Endocrinol; 2021 Jan; 184(1):143-151. PubMed ID: 33112277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of Premenopausal Hysterectomy and Oophorectomy With Breast Cancer Among Black and White Women: The Carolina Breast Cancer Study, 1993-2001.
    Robinson WR; Nichols HB; Tse CK; Olshan AF; Troester MA
    Am J Epidemiol; 2016 Sep; 184(5):388-99. PubMed ID: 27555487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excess morbidity and mortality associated with underuse of estrogen replacement therapy in premenopausal women who undergo surgical menopause.
    Ferris JS; Suzuki Y; Prest MT; Chen L; Elkin EB; Hur C; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2024 Jun; 230(6):653.e1-653.e17. PubMed ID: 38365100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian cancer risk after salpingectomy: a nationwide population-based study.
    Falconer H; Yin L; Grönberg H; Altman D
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25628372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort.
    Gaudet MM; Gapstur SM; Sun J; Teras LR; Campbell PT; Patel AV
    Obstet Gynecol; 2014 Jun; 123(6):1247-1255. PubMed ID: 24807324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premenopausal gynecologic surgery and survival among black and white women with breast cancer.
    Roberson ML; Nichols HB; Olshan AF; A Troester M; Robinson WR
    Cancer Causes Control; 2020 Feb; 31(2):105-112. PubMed ID: 31828465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark.
    Hjorth CF; Damkier P; Ejlertsen B; Lash T; Sørensen HT; Cronin-Fenton D
    BMC Med; 2021 Sep; 19(1):235. PubMed ID: 34587961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
    Eleje GU; Eke AC; Ezebialu IU; Ikechebelu JI; Ugwu EO; Okonkwo OO
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012464. PubMed ID: 30141832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer rate after oophorectomy: A Prospective Danish Cohort Study.
    Koch T; Jørgensen JT; Christensen J; Dehlendorff C; Priskorn L; Simonsen MK; Duun-Henriksen AK; Andersen ZJ; Juul A; Bräuner EV; Hickey M
    Int J Cancer; 2021 Aug; 149(3):585-593. PubMed ID: 33729548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study.
    Harrington LB; Weiss NS; Wiggins KL; Heckbert SR; McKnight B; Blondon M; Woods NF; LaCroix AZ; Psaty BM; Smith NL
    Menopause; 2016 Feb; 23(2):143-9. PubMed ID: 26757272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Diabetes After Hysterectomy With or Without Oophorectomy in Postmenopausal Women.
    Luo J; Manson JE; Urrutia RP; Hendryx M; LeBlanc ES; Margolis KL
    Am J Epidemiol; 2017 May; 185(9):777-785. PubMed ID: 28338878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of stroke after bilateral salpingo-oophorectomy at hysterectomy for benign diseases: A nationwide cohort study.
    Lai JC; Chou YJ; Huang N; Chen HH; Wang KL; Wang CW; Shen IH; Chang HC
    Maturitas; 2018 Aug; 114():27-33. PubMed ID: 29907243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
    Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term cancer risk after hysterectomy on benign indications: Population-based cohort study.
    Altman D; Yin L; Falconer H
    Int J Cancer; 2016 Jun; 138(11):2631-8. PubMed ID: 26800386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
    Anderson GL; Chlebowski RT; Aragaki AK; Kuller LH; Manson JE; Gass M; Bluhm E; Connelly S; Hubbell FA; Lane D; Martin L; Ockene J; Rohan T; Schenken R; Wactawski-Wende J
    Lancet Oncol; 2012 May; 13(5):476-86. PubMed ID: 22401913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.